Product Images Estradiol

This is a description of a medication containing 0.025 mg/day of Estradiol delivered through a Transdermal System. It is prescribed and each system contains 0.314 mg of estradiol along with inactive components such as adhesives, alcohol, and film. The package is not child-resistant and should not be kept within reach of children. The medication should be applied immediately upon removal and should not be stored unpouched. It can be stored between 20" to 25°C with permitted excursions. This medication is distributed by Amneal Pharmaceuticals LLC.*

This is a prescription-only Estradiol Transdermal System that delivers 0.0375 mg/day twice weekly. Each 2.83 cm² system contains 0.470 mg of estradiol, USP. It comes with inactive components like acrylc achesive, siicone adhesie, oleyl alcohol, povidone and dipropylene glycol. This transdermal system is not child-resistant, so it is important to keep it out of the reach of children, and apply it immediately upon removing it from the pouch. It should be stored at a temperature between 20 to 25°C (68°F to 77°F); excursions permitted between 15-30°C (59°F to 86°F) [USP Controlled Room Temperature]. This product has been distributed by Amneal Pharmaceuticals, LLC and the package has been revised in December 2021.*

This text describes a medication product that comes in a 3.78 e system and contains 0.627 mg of estradiol. It includes details about its inactive components, storage instructions, and an important warning regarding its child-resistant packaging. The product is distributed by Amneal Pharmaceuticals LLC based in Bridgewater, NJ.*

Not available.*

This is a description of a medication called "Estradiol Transdermal System, USP", which is a patch that delivers 0.075 mg of estradiol twice a week. The patch is a 5.66 cm² system that contains 0.940 mg of estradiol and is applied immediately upon removal from the pouch. The inactive components of the patch include acrylic adhesive, silicone adhesive, oleyl alcohol, povidone, and dipropylene glycol. The patch should be stored at 20°C to 25°C and kept out of the reach of children. It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

This is a product description for a 7.55 cm² system with 1.253 mg of estradiol, USP. The system includes acrylic adhesive, silicone adhesive, oleyl alcohol, povidone, and dipropylene glycol, with a polyester and ethylene vinyl acetate copolymer film, and a polyester release liner. This product is prescription-only and should be kept out of the reach of children. It should be applied immediately after removal from its pouch, and not stored unpouched. The product should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). It is distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*

This is not-available. The text consists of seemingly random combinations of letters, numbers, and symbols, and it is not possible to generate a useful description from it.*

This appears to be a graph depicting concentration levels (measured in pg/mL) over time (measured in days) for different doses of an unknown substance. The x-axis shows the time in days and the y-axis shows the concentration in pg/mL. The graph has five data points representing the concentration for different doses ranging from 0.0375 mg/day to 0.1 mg/day. The graph appears to have a positive correlation, meaning that as the dose increases, the concentration also increases. There is not enough context to determine the purpose or nature of the substance being measured.*

This is a data table showing the percentage change from baseline in response to different treatments over the course of weeks 2, 7, and 104. The treatments include different doses of Estradiol and a placebo.*

This appears to be a table showing the results of a study or experiment with different treatments and their duration. The treatments include Estradiol administered in varying doses and a placebo. The data presented shows the percentage change from baseline at different durations (Week 26, 52, 78, and 104). However, there is some unclear text mixed in with the table headers, such as "ABCVSP" and "BN lLoanmnwroo~". Without further context, it's difficult to determine what these mean.*

This is a visual representation of the schedule and days for changing the Estradiol Transdermal System patch. It appears that the patch should be changed only on two specific days, as indicated by the vertical bars separating Sned/ThuiSun and TuefFr/savTue. The days of the week are also listed.*